# | Title | Journal | Year | Citations |
---|
1 | Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study | Lancet Infectious Diseases, The | 2010 | 2,485 |
2 | Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? | Nature Reviews Microbiology | 2007 | 1,255 |
3 | Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda | Lancet Infectious Diseases, The | 2002 | 678 |
4 | Challenges in liver cancer and possible treatment approaches | Biochimica Et Biophysica Acta: Reviews on Cancer | 2020 | 671 |
5 | Automated medical image segmentation techniques | Journal of Medical Physics | 2010 | 505 |
6 | Antimony Toxicity | International Journal of Environmental Research and Public Health | 2010 | 486 |
7 | Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4′-chlorophenyl)thiazol-2-yl] thiosemicarbazide | European Journal of Pharmaceutical Sciences | 1999 | 479 |
8 | Understanding the Mechanism of Bacterial Biofilms Resistance to Antimicrobial Agents | Open Microbiology Journal | 2017 | 465 |
9 | Amine-Modified Graphene: Thrombo-Protective Safer Alternative to Graphene Oxide for Biomedical Applications | ACS Nano | 2012 | 420 |
10 | Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India | New England Journal of Medicine | 2010 | 371 |
11 | Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovani | Journal of Infectious Diseases | 1999 | 333 |
12 | Characterization of Antiplatelet Properties of Silver Nanoparticles | ACS Nano | 2009 | 301 |
13 | Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis | Journal of Experimental Medicine | 2007 | 299 |
14 | What do we know about chronic kidney disease in India: first report of the Indian CKD registry | BMC Nephrology | 2012 | 282 |
15 | Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial | Lancet, The | 2011 | 281 |
16 | Cyanobacteria: an emerging source for drug discovery | Journal of Antibiotics | 2011 | 272 |
17 | Gallic acid: Molecular rival of cancer | Environmental Toxicology and Pharmacology | 2013 | 266 |
18 | Laboratory Diagnosis of Visceral Leishmaniasis | Vaccine Journal | 2002 | 263 |
19 | Thrombus Inducing Property of Atomically Thin Graphene Oxide Sheets | ACS Nano | 2011 | 262 |
20 | Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis | Frontiers in Oncology | 2020 | 260 |
21 | Antioxidant and antibacterial activity of silver nanoparticles synthesized by Cestrum nocturnum | Journal of Ayurveda and Integrative Medicine | 2020 | 258 |
22 | Tuberculosis of the central nervous system | Postgraduate Medical Journal | 1999 | 253 |
23 | Antioxidant activity ofBacopa monniera in rat frontal cortex, striatum and hippocampus | Postgraduate Medical Journal | 2000 | 251 |
24 | Evaluation of Chenopodium ambrosioides oil as a potential source of antifungal, antiaflatoxigenic and antioxidant activity | International Journal of Food Microbiology | 2007 | 250 |
25 | Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use | Clinical Infectious Diseases | 2012 | 247 |
26 | Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots | Biomaterials | 2012 | 233 |
27 | Drug Uptake and Modulation of Drug Resistance in Leishmania by an Aquaglyceroporin | Journal of Biological Chemistry | 2004 | 232 |
28 | Rapid accurate field diagnosis of Indian visceral leishmaniasis | Lancet, The | 1998 | 225 |
29 | Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study | Phytomedicine | 2000 | 223 |
30 | Trial of oral miltefosine for visceral leishmaniasis | Lancet, The | 1998 | 222 |
31 | Emergence of vancomycin resistant Staphylococcus aureus(VRSA) from a tertiary care hospital from northern part of India | BMC Infectious Diseases | 2006 | 222 |
32 | Posterior leukoencephalopathy syndrome | Postgraduate Medical Journal | 2001 | 220 |
33 | Molecular Analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 Strains: Clonal Relationships between Clinical and Environmental Isolates | Applied and Environmental Microbiology | 2001 | 217 |
34 | An update on pharmacotherapy for leishmaniasis | Expert Opinion on Pharmacotherapy | 2015 | 213 |
35 | Drug resistance in leishmaniasis | Journal of Global Infectious Diseases | 2010 | 210 |
36 | Bio‐control and plant growth promotion potential of siderophore producing endophytic Streptomyces from Azadirachta indica A. Juss. | Journal of Basic Microbiology | 2011 | 210 |
37 | Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum | Journal of Ethnopharmacology | 2001 | 209 |
38 | Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one | Pharmaceutica Acta Helvetiae | 1999 | 208 |
39 | Leishmaniasis: an update of current pharmacotherapy | Expert Opinion on Pharmacotherapy | 2013 | 207 |
40 | Diagnosis of visceral leishmaniasis | Transactions of the Royal Society of Tropical Medicine and Hygiene | 2011 | 205 |
41 | Antihyperglycemic Activity of Phenolics fromPterocarpus marsupium | Journal of Natural Products | 1997 | 203 |
42 | Prevalence and Associated Risk Factors of Hypertension: A Cross-Sectional Study in Urban Varanasi | International Journal of Hypertension | 2017 | 196 |
43 | Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma | Cell Host and Microbe | 2015 | 195 |
44 | Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980–2004 | Lancet Infectious Diseases, The | 2005 | 194 |
45 | Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders | Nanomedicine | 2009 | 192 |
46 | Chitosan as a promising natural compound to enhance potential physiological responses in plant: a review | Indian Journal of Plant Physiology | 2015 | 188 |
47 | Molecular mechanisms of antimony resistance in Leishmania | Journal of Medical Microbiology | 2007 | 186 |
48 | RESULTS OF TREATMENT OF SPINAL TUBERCULOSIS BY " MIDDLE-PATH" REGIME | Journal of Bone and Joint Surgery: British Volume | 1975 | 184 |
49 | Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants – Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) – a molecular docking study | Journal of Biomolecular Structure and Dynamics | 2022 | 181 |
50 | Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats | Neuroscience Research | 1991 | 180 |